Inflammatory breast cancer (IBC) is the most deadly form of breast cancer in humans presumably due to its ability to metastasize from its inception. In our laboratory, overexpression of RhoC GTPase was observed to be specific for IBC tumors, but not for stage-matched, non-IBC tumors. RhoC is known to contribute to an IBC-like phenotype in HPV-E6E7 immortalized breast cells. To further study the effect of RhoC overexpression on IBC metastasis, we generated stable transfectants of spontaneous immortalized mammary epithelial cells (MCF10A) overexpressing wild-type RhoC or a constitutively active RhoC mutant (G14V). Both the RhoC wild type and the G14V transfectants were highly invasive and proliferated more rapidly compared to vector-only control clones. Overexpression of RhoC led to an increase in actin stress fiber and focal adhesion contact formation. Comparative microarray analysis of these clones further revealed that RhoC overexpression upregulated 108 genes whereas seven genes were down-regulated. We have further verified by quantitative RT-PCR that genes involved in cell proliferation, invasion/adhesion, and angiogenesis were modulated by RhoC. This work suggests strong candidates for the downstream oncogenic functions of RhoC.
Introduction
Primary IBC is the most lethal form of breast cancer and accounts for approximately 6% of new breast cancer cases annually in the United States [1, 2] . IBC is clinically well characterized by a very rapid onset of skin changes such as erythema, skin nodules, dimpling of the skin (termed 'peau d'aurange'), and nipple retraction, typically within six months [1] [2] [3] [4] . IBC cells acquire metastatic capabilities early in tumor formation; nearly all women with IBC have tumor emboli that are present in the dermal lymphatics at the time of diagnosis, and over one-third have distant metastases [3, 4] . In spite of modern multimodality treatments, the 5-year disease-free survival is less than 45%, thus making IBC the most deadly form of locally advanced breast cancer [3, 4] .
In our laboratory, we sought to identify the genetic basis of IBC development and progression [5] . Overexpression of RhoC GTPase [6] and down-regulation of WISP3 [7] are characteristic and specific for IBC, in work performed on SUM149, an IBC cell line [8] . Moreover, overexpression of RhoC GTPase was identified in 90% of IBC archival tumor samples, but not in stage III non-IBC tumors [5] .
RhoC belongs to the Ras superfamily of small GTPase, which includes RhoA and RhoB (homologous to RhoC) as well as many others, including Rac and Cdc42 [9] . Upregulation of RhoC plays important roles in metastasis not only in IBC, but also in a plethora of malignant neoplasms including bladder [10] , ovary [11] , pancreas [12] , and skin (melanoma) [13] . However, RhoC signaling and its downstream molecular targets involved in IBC progression are still poorly understood.
In order to gain further insight into RhoC downstream signaling, we have developed breast-specific cellular reagents that would allow us to study the gene expression changes caused by RhoC upregulation. Stable transfectants of wild-type RhoC (RhoC-WT) and a constitutively active RhoC mutant (G14V) were generated in human mammary epithelial cells. We performed oligonucleotide/cDNA microarray comparative analysis of these clones and vector-only transfectants. Our laboratory had previously established stable wild-type RhoC transfectants in HPV-E6/E7 immortalized human mammary epithelial cells (termed HME-E6/E7), which acquired an aggressive IBC-like phenotype, including high motility and invasiveness, ability to grow on soft agar, and ability to form tumors in nude mice [6] .
For studies of gene expression changes, we aimed to develop cellular reagents that isolated RhoC overexpression as a genetic event, independent of viral immortalization of the parental cell line. In this study, we employed RhoC constructs (Guthrie cDNA Resource Center) which comprise only the coding region of RhoC with three HA-tags at the N-terminus in pcDNA3.1 (Invitrogen, Carlsbad, CA). To avoid potential phenotype changes associated with immortalization, we used MCF10A cells as the parental substrate. MCF10A was derived from the proliferative epithelium of a fibrocystic lesion [14] . Importantly, biological assays showed that the MCF10A-RhoC WT and the G14V transfectants exhibited enhanced invasion and cell proliferation quantitatively comparable to the original HME E6/E7 clones. The formation of stress fibers and focal adhesion in these cells was significantly increased, which is also characteristic in cells overexpressing Rho family proteins [9] , further supporting that over-expression of RhoC morphologically transformed MCF10A cells.
Overall, the array analysis of our wild-type/G14V RhoC clones lends strong support for a role of RhoC in invasion and metastasis. The data showed increased expression in 105 genes, and decreased expression in seven genes. We confirmed RhoC-induced differential expression in several genes using RT-PCR. Here we present the first summary data of genome-wide expression changes induced by RhoC overexpressionmediated transformation of breast cells.
Materials and methods

Cell culture
MCF10A cells [14] were cultured in 1:1 mixture of Ham's F12 (Mediatech, Herndon, VA) and DMEM containing L-glutamine (Invitrogen, Carlsbad, CA), supplemented with 5% horse serum (Invitrogen, Carlsbad, CA), EGF, cholera toxin, insulin, hydrocortisone (Sigma, St. Louis, MO) at 37 • C under 10% CO 2 . MCF10A cells are cytokeratin positive luminal cells, which correlates with the histologic type of the IBC SUM149 [15] . MCF10A cells were transfected with either pcDNA3.1 (Invitrogen, Carlsbad, CA), pcDNA3.1-RhoC wildtype or with pcDNA3.1-RhoC constitutively active G14V mutant (Guthrie cDNA Resource Center, http://www.cdna.org), using FuGene 6 (Roche Applied Science, Indianapolis, IN). Stable transfectants were developed as previously described [6] and maintained in the medium supplemented with 600 µg/ml G418 (Invitrogen, Carlsbad, CA).
Western analysis
Cells were washed in ice-cold phosphate-buffered saline, lysed in lysis buffer (10% glycerol, 50 mM Tris pH 7.4, 100 mM NaCl, 1% NP-40, 2 mM MgCl 2 , 1 µg/ml leupeptin, 1 µg/ml aprotinin, 1 mM PMSF) on ice for 5 min, and then centrifuged for 5 min at 4 • C. Cleared lysates (50 µg of protein each) were subjected to SDS-PAGE and transferred to PVDF membrane. Western blots were performed as described [16] using the anti-RhoC rabbit polyclonal antibody [16] , the anti-HA monoclonal antibody (Covance, Princeton, NJ) and anti-β-actin goat antibody (Sigma, St. Louis, MO) at dilutions of 1:1500, 1:1200 and 1:2000, respectively.
Quantitative RT-PCR
Total messenger RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) per the manufacturer's instruction. One microgram of total RNA was converted to cDNA using an avian myeloblastosis virus reverse transcription system (Promega, Madison, WI). A 100-mg aliquot of the resulting cDNA was amplified in a double PCR with 25 ng each of HA/GAPDH-specific primers or with the sequencespecific primers for the genes of interest. PCR products were separated on a 1.2% agarose gel and imaged on an Alpha Image 950 documentation system (Alpha Innotech, San Leandro, CA). Densitometry of the images was performed using AlphaEaseFC (Alpha Innotech, San Leandro, CA).
Cell staining of HA-tagged RhoC and rhodamine-phalloidin
Cells were grown on chamber slides for 24 h and washed with PBS followed by fixation with 3% paraformaldehyde in PBS for 10 min. After incubating in 0.1% Triton and blocking in 1% BSA, 2 Units of methanolic rhodamine-phalloidin stock (Molecular Probes, Eugene, OR) or 1:1000 dilution of the anti-HA monoclonal antibody (Covance, Princeton, NJ) in 200 µl PBS were added to each coverslip and allowed to stain for 1 h at room temperature. The samples containing anti-HA were further stained with 1:400 dilution of Alexa Fluor 488-conjugated anti-mouse secondary antibody (Molecular Probes, Eugene, OR). All the slides were mounted by Gel/Mount (Biomedia Co., Foster City, CA). Cells were visualized under an Olympus fluorescence microscope.
Monolayer growth rate
Monolayer culture growth rate was determined by conversion of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma, St. Louis, MO) to a water-insoluble formazan by viable cells. Fivehundred cells in 200 ml of medium were plated in 96-well plates and grown under normal conditions. Cultures were assayed at 1, 3, 5, 7, 9, and 11 days by adding 40 ml of 5 mg/ml MTT and incubating for 1 h at 37 • C. The medium was aspirated and 100 ml of DMSO (Sigma, St. Louis, MO) were added to lyse the cells and solubilized the formazan. Absorbance values of the lysates were determined on a Dynatech MR 5000 microplate reader at 595 nm.
Quantitative invasion assay of the stable transfectants
Invasion assays were performed on 24-well culture dishes per manufacturer's instructions (Chemicon International, Temecula, CA). The inserts within each dish are equipped with a polycarbonate membrane on the bottom coated with a thin layer of extracellular matrix (ECM) proteins. In brief, the inserts were rehydrated in serum-free media. Cells were washed in PBS and resuspended in serum-free medium at a concentration of 5 × 10 5 cells/ml and 0.5 ml of cell suspension was added to the insert. Wells in the culture dish were filled with serum-containing medium. The dish was incubated for 24 h at 37 • C in a 10% CO 2 incubator. The cell suspension was aspirated and noninvasive cells were removed from the insert using a cotton swab. The inserts were stained with the staining solution for 20 min, then rinsed in water. Stained cells were dissolved in 10% acetic acid, and measured OD at 595 nm.
Microarray procedures
DNA microarray analysis of gene expression was carried out as previously described [17] . Briefly, purified PCR products, generated using clone inserts (sequence verified Human cDNA clones from ResGen, Carlsbad, CA) as template, were spotted onto poly-L-lysine coated microscope slides using an Omnigrid robotic arrayer (GeneMachines, San Carlos, CA) equipped with quill-type pins (Majer Precision Engineering, Tempe, AZ) to generate 20,000 element human cDNA microarrays. Protocols for printing and post-processing of arrays are available in the public domain [18] .
Isolation of RNA, labeling of cDNA probes and hybridization to cDNA arrays
Approximately 4-6 million cells per 100-mm tissue culture plate were harvested in Trizol (Invitrogen, Carlsbad, CA) and total RNA was isolated according to the manufacturer's protocol. An extra phenol-chloroform extraction was performed to improve the quality of RNA for microarray analyses. Total RNA was quantified, RNA integrity adjusted by denaturing-formaldehyde agarose gel electrophoresis, and stored in aliquots at −80 • C until ready to use. Forty micrograms of total RNA was routinely used as template for cDNA generation using reverse transcriptase (RT) (Invitrogen, Carlsbad, CA). Inclusion of amino allyl-dUTP (Sigma, St. Louis, MO) in the RT reaction allowed for subsequent fluorescent labeling of cDNA using mono-functional NHS ester dyes (Amersham Biosciences, Piscataway, NJ) as described [18] . For every hybridization, fluorescent cDNA probes were prepared from RNA from RhoCtransfected cells (coupled to Cy5 NHS-ester) and matched vector transfected reference cells (coupled to Cy3 NHS-ester). The labeled probes were then hybridized to the 20 K human cDNA microarrays at 65 • C overnight as described [18] . Fluorescent images of hybridized microarrays were obtained using a GenePix 4000A microarray scanner (Axon Instruments, Union City, CA).
Results
Identification and confirmation of MCF10A-RhoC/G14V overexpressing clones
In order to isolate the MCF10A-RhoC-WT/G14V stable transfectants, quantitative RT-PCR and western analysis were conducted. Using primers specifically designed to amplify HA tags and their junction with RhoC, RT-PCR revealed a 5-fold increase in HA-RhoC mRNA in the MCF10A-RhoC transfectants (Figure 1(A) ). The levels of RhoC expression correlated well with those of the primary SUM149 cell line and the previously described HME-RhoC transfectants [5, 6] . Western analysis further confirmed that the RhoC protein levels in the MCF10A-RhoC cells are approximately two-fold higher than in the vectoronly controls (Figure 1(B) ). For further verification, we also tested HA-RhoC protein levels and protein localization in the transfectants using immunofluorescence staining (Figure 2 , HA MoAb). As expected, the MCF10A-RhoC clones stained very strongly with a monoclonal antibody against HA compared to the vector only control. Based on the RT-PCR and western analysis, we selected two clones each for both MCF10A-RhoC WT and MCF10A-G14V for our subsequent studies.
Overexpression of RhoC in MCF10A-RhoC increased stress fiber formation, monolayer growth rates, and invasion
The most prominent function of the Rho family proteins is to induce the assembly of actin and myosin filaments (stress fibers), to enhance focal adhesions, and to act collaboratively with Rac and Cdc42 in cell movement [9] . RhoC overexpression in HME E6/E7 is known to enhance formation of stress fibers [6] . In our new MCF10A-RhoC WT transfectants, we have likewise observed significant induction of the assembly of actin filaments, using rhodamine-phalloidin to specifically stain F-actin (Figure 2) . The control cells were round and small; on the other hand, the RhoC WT cells stretched in polygonal shapes and formed multiple focal adhesion points (Figure 2) .
The HME-E6/E7 RhoC clones had not shown significant increase of monolayer growth rate from the control cells [6] . Interestingly, the monolayer growth rate assay of the MCF10A-RhoC WT/G14V cells showed a two-fold increase in proliferating rates compared to the vector-only controls, in three independent experiments (Figure 3(A) ).
Our laboratory had previously established the role of RhoC in inducing an IBC-like invasive phenotype in mammary epithelial cells [6] . We examined the new MCF10A-RhoC clones with a cell invasion assay, containing a Boyden chemotaxis chamber, with the bottom of the insert coated with reconstituted basement membrane matrix. We confirmed that MCF10A-RhoC WT exhibited two-fold increase of cell invasion, and Figure 2 . Fluorescence microscopy of the RhoC transfectants staining with the anti-HA monoclonal antibody (green) to visualize HA-RhoC, or rhodamine-phalloidin (red) to visualize stress fibers. Cells grown on chamber slides were fixed with 3% paraformaldehyde, permeablized with 0.1% Triton X-100, and blocked with 1% BSA. The samples were incubated with either the primary anti-HA antibody and the Alexa Fluor 488-conjugated secondary antibody, or rhodamine-phalloidin.
the RhoC G14V cells had three-fold higher invasion than controls (Figure 3(B) ).
Microarray analysis of the MCF10A-RhoC WT/G14V transfectants
Primary analysis of gene expression in MCF10A-RhoC WT/G14V, along with MCF10A-vector as controls, was done using the Genepix software package (Axon Instruments, Union City, CA). Cy5 to Cy3 ratios were determined for the individual genes along with various other quality control parameters (e.g., intensity over local background). Bad spots and defective areas on the array were inspected and manually flagged. Spots with small diameters (<50 microns) and spots with low signal strengths <350 fluorescence intensity units over local background in the more intense channel were also discarded. These data files were then imported into a Microsoft Access database and filtered for presence of data points across arrays and selected for change in expression levels by 2-fold or more.
SAM analysis [19] was performed by comparing gene expression profiles of four RhoC overexpressing clones (two MCF10A-RhoC WT and two MCF10A-G14V clones) against two RhoC low-expressing clones. Data were normalized per array by multiplication by a factor to adjust the aggregate ratio of medians to one, then log base two transformed, and median centered. These normalized data were divided into two groups for comparison using a two-class, unpaired t-test. Critical values for the analysis include: Iterations = 200, random number seed 80842225, a fold change cutoff of 1.5 and a delta cutoff of 0.598, resulting in a final largest median false discovery rate of 0.867% for the 115 genes selected as significant (108 relatively up-and seven relatively downregulated between RhoC overexpressing and RhoC low-expressing clones).
Overexpression of RhoC WT/G14V significantly altered message levels of genes involved in invasion and metastasis
In order to help elucidate the downstream signaling of RhoC GTPase, we have selected several significantly upregulated genes from the microarray results and examined their mRNA expression by quantitative RT-PCR. The housekeeping gene GAPDH served as a loading control ( Figure 5(A and B) ). We have found that the message of cyclin D1, a key regulator required for the G1/S transition in the cell cycle [20] was enhanced up to two-fold in the MCF10A-RhoC clones ( Figure 5(A) ). Overexpression of RhoC WT/G14V also increased the expression of two key angiogeneic factors, VEGF-C [21] and CXCL1 chemokine [22] ( Figure 5(A) ). Whereas we observed moderate stimulation of VEGF-C around two-fold, CXC chemokine ligand 1 (CXCL1) expression was highly enhanced to seven-fold in the MCF10A-RhoC WT clone compared to the vector-only controls ( Figure 5(A) ). The mRNA of Caveolin-2, a protein element of caveolar membrane [23] , showed two-fold increase in the MCF10A-RhoC cells ( Figure 5(A) ). Notably as well, RhoC has a significant effect on the message level of fibronectin, a major component of connective-tissue type of ECM [24] (Figure 5(A) ). Both alternatively spliced transcripts of fibronectin [25] were tested and they were equivalently upregulated. Fibronectin and CXCL1 are the two most upregulated genes identified in the array analysis.
On the other hand, we have found that RhoC overexpression decreased the message level of IGFBP-2, a high-affinity IGF binding protein. IGFBP2 is known to function as an inhibitor of IGF, a potent mitogen of breast cancer cells [26] . The mRNA of IGFBP-2 in the MCF10A-RhoC WT and MCF10A-G14V clones was lowered for 70 and 50%, respectively ( Figure 5(B) ) which correlated with and confirmed the array data. This result further supports the role of RhoC in enhancing tumor aggressiveness and perhaps enabling enhanced IGF signaling.
Discussion
In this study, we summarize our initial work to explore the molecular basis for RhoC-induced invasive phenotype in spontaneous immortalized breast cells (MCF10A) using RNA microarray techniques. We have focused our validation experiments on five upregulated gene products involved in cell cycle progression (cyclin D1), angiogenesis (VEGF-C and CXCL1), and cell adhesion (fibronectin), and one down-regulated gene (IGFBP2).
Cyclin D1 is essential for G1 cell cycle progression and its expression is significantly higher in a variety of tumors, notably breast, parathyroid and sarcomas [27] . Inhibition of Rho, as well as Rac and Cdc42, can arrest the cell cycle at G1 [24] . Rac and Cdc42 signaling activate JNK and p38, which in turn stimulate cyclin D1 expression [28] . Conversely, activation of RhoA, a protein highly homologous to RhoC, stimulates transcription of AP-1, a major transcription factor controlling the cyclin D1 promoter [28] . Cyclin D1 transcription is also induced by the integrin-ECM signaling pathway [24] . Interactions between fibronectin and integrin activate focal adhesion kinase (FAK), which, in turn, transmits the signal to Rac and induces cyclin D1 transcription [24] . We have observed significant upregulation of fibronectin in our RhoC clones ( Figure 5(A) ). Therefore, increased cyclin D1 message in RhoC overexpressed breast cells may arise from the concerted effect of RhoC and Rac/Cdc42 signaling or possibly by the effects of fibronectin-dependent integrin activation.
VEGF-C, a member of the vascular endothelial growth factor family, is crucial for new capillary growth from existing vessels [21] . VEGF-C binds with high affinity to the VEGF receptor 3 (VEGFR3), but it also binds to VEGFR2 with low affinity [21] . VEGF/VEGFR signaling is essential for endothelial cell proliferation, chemotaxis, and vascular permeability. Mice carrying a VEGFR2 deletion did not have differentiated blood vessels or capillaries, whereas VEGFR3 knockout mice showed no defects in angiogenesis, but had abnormal vessel permeability causing fluid accumulation [21] . In previous work [29], we showed that RhoC activation induces angiogenesis, likely through p38 signaling. Now we show that the VEGF-C is specifically upregulated by RhoC activation, suggesting a possible role of RhoC also in promoting lymphagiogenesis.
CXCL1 is also known as melanoma growth regulated protein (GRO), as it was first identified from human melanoma conditioned medium [22] . CXC chemokines are heparin-binding proteins with two conserved cysteines flanking one other residue. The Nterminus of many family members (termed as ELR+) contains the ELR motif (Glu-Leu-Arg). The ELR+ chemokines, including CXCL1, are highly effective in promoting angiogenesis in physiological concentration of 1-100 Nm [30] . In melanoma, uncontrolled increases of CXCL1 or CXCL8 chemokines lead to angiogenesis and tumorigenesis, with concomitant constitutively activation of NF-kB. These CXCLoverexpressed melanoma cells also become greatly metastatic [22] .
Fibronectin is a major component of stromal matrices, which are found at sites of injury and inflammation. Cell adhesion to this type of matrices often leads to migration and proliferation, instead of growth arrest and differentiation as occurs in contact with the basement membrane-type of ECM [31] . Transcription of fibronectin is stimulated by cAMP (forskolin) and TGF-β [32] . TGF-β, a potent regulator for cell growth, activates RhoA-dependent signaling and mediates the epithelial-mesenchymal transition and stress fiber formation [33, 34] . In addition, expression of NET1, a Rho GEF, is induced by TGF-β [35] . In contrast, cAMP activates cAMP-dependent kinase (PKA), which phosphorylates and inhibits RhoA [36] . Taken together based on these data, we propose that RhoC overexpression may help enhance TGF-β signaling thereby enhancing fibronectin expression.
Our results also indicate that caveolin-2 is upregulated in the RhoC overexpressing breast cells ( Figure 5(A) ). Caveolins are major structural proteins of caveolae, which are plasma membrane invaginations found in many cell types, including fibroblasts, epithelial cells and endothelial cells [37] . These membrane ruffles support and concentrate growth factor receptors and their immediate downstream signaling. The caveolin gene family consists of three members, caveolin-1, -2, and -3. Caveolin-1 is known to form homodimers or heterodimers with caveolin-2 in caveolae biosynthesis [37] . The function of caveolin-2 in human cancer is very poorly understood, compared to the family member caveolin-1. The caveolin-1 gene is frequently deleted in human chromosome in a plethora of cancers, including squamous cell carcinomas, ovarian adenocarcinomas, prostate and breast cancers [37] . Down-regulation of caveolin-1 is also known as a feature of terminally differentiated cells [38] . Furthermore, the molecular mechanism of caveolin-1 as a tumor suppressor was to inhibit Neu tyrosine kinase pathway [39] . Overexpression of caveolin-1 inhibited the Neu pathway, and reduced tumor size in Neu-expressing transgenic mice. Interestingly, oncogenic activation of Neu down-regulated caveolin-1, but not caveolin-2 [39] . Since we have observed moderate increase of caveolin-2 in MCF10A-RhoC, highly invasive breast cells ( Figure 5(A) ), it would be interesting to explore whether caveolin-2 serves a specific role in tumorigenesis in this system.
In our array expression experiments, we have found 108 upregulated genes and only seven downregulated genes when we compared the MCF10A-RhoC WT/G14V clones with MCF10A-Vector and RhoC low-expressing cells (Figure 4) . We identified IGFBP-2 message levels to be lowered in both WT and G14V transfectants using quantitative RT-PCR ( Figure 5(B) ). IGFBP2 is a negative regulator of the IGF system. IGF (insulin-like growth factors) are important mediators of cell growth and development. They are synthesized by nearly all tissues in the body and their functions are regulated by receptor tyrosine kinases in a complex circuitry of signaling. In breast cell carcinogenesis, IGF-1 increases cancer cell proliferation through two mechanisms. IGF-1 enhances cancer cell growth and also promotes stromal cell outgrowth in a paracrine or autocrine manner [26] . IGFBP3, also a high-affinity inhibitor to IGFs, repressed IGF signaling in breast cancer cells even without physical interactions with IGF [40] . Furthermore, WISP3/LIBC, a tumor suppressor first identified in our laboratory, was predicted as a member of IGFBP-rPs by its protein sequence [5] . IGFBP-rP proteins show relatively low affinity for IGF binding so they may regulate cell growth by mechanisms other Figure 5 . Quantitative RT-PCR analysis of the RhoC clones. Sequence-specific primer pairs were designed to amplify cyclin D1, caveolin-2, VEGF-C, fibronectin, CXCL1, and IGFBP2 (the mRNA sequences of the above genes were downloaded from Genbank, NCBI, NIH). In the RT-PCR reaction, 100 mg of cDNA was amplified with 25 ng each of the primers. The products were separated on a 1.2% agarose gel. GAPDH was served as a loading control.
than direct binding to IGF. IGFBP-rP1 was also proposed to be a potential tumor suppressor protein for prostate cancer [26] . In conclusion, down-regulation of IGFBP2 by RhoC supports that RhoC overexpression may enhance an IBC-like, invasive phenotype in normal breast cells by modulation of IGF signaling. Taken together, our data present a number of key molecules that are likely to be involved in the phenotype changes induced by RhoC, suggesting future investigations in this area.
